Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Eagle Pharmaceuticals

Youtube Subscribe

...

Ticker: EGRX

Sector: Biotechnology

Eagle Pharmaceuticals Inc. reiterates 2023 adjusted non-GAAP EBITDA guidance for the 2023 fiscal year. CEO Scott Tarriff: We believe Eagle is on the path to generating sustained-term growth..
...
...
Extended Summary

Eagle Pharmaceuticals

Eagle Pharmaceuticals Inc. reiterates 2023 adjusted non-GAAP EBITDA guidance for the 2023 fiscal year. CEO Scott Tarriff: We believe Eagle is on the path to generating sustained-term growth

Related Results

...
February 10, 2024 15:29 (London Time)

Eagle Pharmaceuticals

Eagle Pharmaceuticals (NASDAQ:EGRX) and Verona Pharma (NASdaq:VRNA) are both small-cap medical companies, but which is the superior stock? We will c…
Sector: Biotechnology
Ticker: EGRX
Sentiment: -0.8519
MarketCap: 69,090,685.0
High: 5.47 Low: 5.18

Open: 5.33 Close: 5.32 Change: -0.01

Read more →
...
December 12, 2023 19:47 (London Time)

Eagle Pharmaceuticals

Bragar Eagel & Squire, P.C. is investigating potential claims against Eagle Pharmaceuticals, Inc. (Eagle Pharmaceuticals) Scott Tarriff, Founder, Pr…
Sector: Biotechnology
Ticker: EGRX
Sentiment: -0.8591
MarketCap: 70,714,057.0
High: 5.52 Low: 5.25

Open: 5.45 Close: 5.36 Change: -0.09

Read more →
...
August 20, 2023 0:08 (London Time)

Eagle Pharmaceuticals

Eagle Pharmaceuticals Inc. reiterates 2023 adjusted non-GAAP EBITDA guidance for the 2023 fiscal year. CEO Scott Tarriff: We believe Eagle is on the…
Sector: Biotechnology
Ticker: EGRX
Sentiment: 0.3818
MarketCap: 226,492,774.0
High: 18.33 Low: 17.42

Open: 17.64 Close: 17.44 Change: -0.2

Read more →
...
December 17, 2023 8:31 (London Time)

Eagle Pharmaceuticals

Eagle Pharmaceuticals stock dropped $4.16 per share, or 30.36%, to close at $9.54 on November 9, 2023. Scott Tarriff, Founder, President and Chief E…
Sector: Biotechnology
Ticker: EGRX
Sentiment: -0.128
MarketCap: 60,129,675.0
High: 5.09 Low: 4.62

Open: 4.95 Close: 4.63 Change: -0.32

Read more →
...
October 31, 2023 4:34 (London Time)

Eagle Pharmaceuticals

TailorMed Partners with Eagle Pharmaceuticals to Streamline Patient Financial Assistance Enrollment. Partnership aims to reduce financial barriers t…
Sector: Biotechnology
Ticker: EGRX
Sentiment: 0.7351
MarketCap: 180,259,157.0
High: 13.93 Low: 13.43

Open: 13.71 Close: 13.88 Change: 0.17

Read more →
Search
Happening Now
Categories